A pilot study of change in fracture risk in patients with acute respiratory distress syndrome. by Rawal, J et al.
Rawal et al. Critical Care  (2015) 19:165 
DOI 10.1186/s13054-015-0892-yRESEARCH Open AccessA pilot study of change in fracture risk in patients
with acute respiratory distress syndrome
Jaikitry Rawal1, Mark JW McPhail2,3, Gamumu Ratnayake4, Pearl Chan1, John Moxham5, Stephen DR Harridge6†,
Nicholas Hart4†, Hugh E Montgomery1† and Zudin A Puthucheary1,7*†Abstract
Introduction: Acute skeletal muscle wasting is a major contributor to post critical illness physical impairment.
However, the bone response remains uncharacterized. We prospectively investigated the early changes in bone
mineral density (BMD) and fracture risk in critical illness.
Methods: Patients were prospectively recruited ≤24 hours following intensive care unit (ICU) admission to a
university teaching or a community hospital (August 2009 to April 2011). All were aged >18 years and expected to
be intubated for >48 hours, spend >7 days in critical care and survive ICU admission. Forty-six patients were studied
(55.3% male), with a mean age of 54.4 years (95% confidence interval (CI): 49.1 to 59.6) and an APACHE II score of
23.9 (95% CI: 22.4 to 25.5). Calcaneal dual X-ray absorptiometry (DXA) assessment of BMD was performed on day 1
and 10. Increase in fracture risk was calculated from the change in T-score.
Results: BMD did not change between day 1 and 10 in the cohort overall (0.434 (95% CI: 0.405 to 0.463) versus
0.425 g/cm2 (95% CI: 0.399 to 0.450), P = 0.58). Multivariable logistical regression revealed admission corrected
calcium (odds ratio (OR): 1.980 (95% CI: 1.089 to 3.609), P = 0.026) and admission PaO2-to-FiO2 ratio (OR: 0.916 (95%
CI: 0.833 to 0.998), P = 0.044) to be associated with >2% loss of BMD. Patients with acute respiratory distress
syndrome had a greater loss in BMD than those without (−2.81% (95% CI: −5.73 to 0.118%), n = 34 versus 2.40%
(95% CI: 0.204 to 4.586%), n = 12, P = 0.029). In the 34 patients with acute respiratory distress syndrome, fracture risk
increased by 19.4% (95% CI: 13.9 to 25.0%).
Conclusions: Patients with acute respiratory distress syndrome demonstrated early and rapid bone
demineralisation with associated increase in fracture risk.Introduction
Rapid and early muscle wasting contributes to the sig-
nificant long-term functional impairment observed in
survivors of critical illness [1-4]. Although muscle and
bone mass correlate in healthy individuals [5-7], there
are limited data reporting the impact of critical illness
on bone health. During acute critical illness, mechanical
unloading as a consequence of bed rest [8], inflamma-
tion [9], acidaemia [10], vitamin D deficiency [11], cor-
ticosteroid use [12] and hypoxia [13] may all worsen
bone health and reduce bone mineral density (BMD).* Correspondence: Zudin_amilka_puthucheary@nuhs.edu.sg
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unless otherwise stated.Indeed, markers of bone turnover increase during crit-
ical illness [11,14]. Such bone demineralization may ex-
plain symptoms of generalised musculoskeletal pain in
survivors of critical illness [1,2], and the reported in-
crease in fracture risk in elderly females following crit-
ical illness [15]. However, the bone response to critical
illness has never before been prospectively studied. We
thus performed a pilot study to investigate the early ef-
fects of critical illness on BMD and fracture risk, and
also sought clinical factors that might be associated with
early bone demineralization.
Materials and methods
Subjects comprised a subgroup of the Musculoskeletal
Ultrasound in Critical Illness: Longitudinal Evaluation
cohort (trial registered with Clinicaltrials.gov, identifier:
NCT01106300) [4]. Ethical approval was obtained fromThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Characteristics of patients who had serial
measurements versus those who only had admission
measurements
Serial DEXA
measurements
Single DEXA
measurement
P value
N 46 11 -
Age 55.09 (49.9-60.3) 53.9 (40.6-67.1) 0.93
Male sex, n (%)b 26 (55.3) 6 (60) 0.74
Pre-ICU LOSa 1 (1-45) 1 (1-6) 0.25
APACHE II score 24 (22.4-25.6) 27.1 (21.9-32.3) 0.12
SAPS II score 40.9 (37.5-44.3) 53.3 (44.2-62.4) <0.01c
Admission SOFA score 9.3 (8.5-10.0) 8.6 (5.8-11.4) 0.50
Admission diagnosis, n (%)
Cardiogenic shock 6 (13.0) 3 (33.3)
Trauma 12 (26.1) 2 (20.0)
Acute renal failure 1 (2.2) 2 (20.0)
Intra cranial haemorrhage 5 (10.9) 1 (10.0)
Acute liver failure 4 (8.7) 1 (10.0)
Severe sepsis 16 (34.8) 1 (10.0)
Major haemorrhage 2 (4.3) 0 (0.0)
Co-morbidities, n (%)
Ischaemic heart disease 5 (10.9) 3 (33.3)
Liver cirrhosis 6 (13.0) 0 (0.0)
Haematological disease 2 (4.3) 1 (10.0)
Hypertension 9 (19.6) 1 (10.0)
Obesity 2 (4.3) 0 (0.0)
COPD 7 (15.2) 0 (0.0)
Diabetes mellitus 5 (10.9) 0 (0.0)
Previous CVA 1 (2.2) 0 (0.0)
Chronic pancreatitis 1 (2.2) 0 (0.0)
Thyroid disease 3 (6.5) 0 (0.0)
Crohn’s disease 1 (2.2) 0 (0.0)
Renal impairment 2 (4.3) 0 (0.0)
Small bowel insufficiency 0 (0.0) 1 (10.0)
APACHE II = Acute Physiology and Chronic Health Evaluation II, COPD= Chronic
Obstructive Pulmonary Disease, CVA = Cerebro Vascular Accident, DEXA =Dual
X-ray Absorptiometry, ICU = Intensive Care Unit, LOS = Length of Stay, SAPS II =
Simplified Acute Physiology Score, SOFA = Sequential Organ Failure Assessment.
Values are mean (95% confidence intervals), except for aindicating median with
range. Student’s T-test was used except for b(chi-squared) and a(Mann Whitney
U);c indicates P <0.05.
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were recruited within 24 hours of admission to a university
hospital (Kings College Hospital NHS Foundation Trust) or
a community hospital intensive (Whittington Hospital NHS
Trust) care unit (ICU) between August 2009 and April 2011.
All were anticipated to be invasively ventilated for more than
48 hours, spend more than 7 days in the ICU and survive
their ICU stay. Patients who were pregnant or suffering
lower limb amputation, primary neuromuscular disease or
cancer were excluded. At enrolment, written assent was
obtained from the next-of-kin, with retrospective patient
consent obtained when full mental capacity was regained.
BMD was assessed using dual X-ray absorptiometry
(DXA) imaging on day 1 and day 10 (DXL Calscan,
Demetech AB, Sweden), which has a coefficient of vari-
ance of 0.9%. Fracture risk was calculated from a change
in T-score whereby the relative risk of a major osteopor-
otic fracture increases 1.5-fold (95% confidence interval
(CI): 1.4 to 1.6) per standard deviation below the mean
T-score [16]. Detailed clinical and physiological bedside
data were collected, as previously described [4].
Statistical analysis
All data were assessed for normality using D’Agostino and
Pearson omnibus normality tests, and analyzed using
Student’s t-test, Pearson’s coefficient, Mann-Whitney U
test and Wilcoxon’s signed rank tests, as appropriate. For
the purposes of hypothesis generation in this pilot study,
we sought a parsimonious model of associated physio-
logical factors. Age, sex and chronic disease were forced
into bivariable logistical regression (Statistical Package for
the Social Sciences version 17; SPSS Inc., Chicago, IL,
USA) using a threshold of 2% loss of BMD, which is twice
the expected loss from bed rest alone [8]. Statistically sig-
nificant independent variables from the bivariable analysis
were entered into a backward multivariable analysis if the
P value was 0.10 or less.
Results
Fifty-seven patients assented to serial DXA scanning. Of
these, seven did not survive ten days, one was transferred
to another hospital, one withdrew from the study, one
was discharged before day ten and one was unable to have
serial scans for technical reasons. Forty-six patients were
included in the final analysis. The characteristics of these
46 patients, shown in Table 1, did not differ from those
withdrawn, except for a higher Simplified Acute Physi-
ology Score (SAPS II) (40.9 (95% CI: 37.5 to 44.3, n = 46)
versus 53.3 (95% CI: 44.2 to 62.4, n = 10); P <0.01). Four
patients had pre-morbid conditions associated with possible
disrupted calcium homeostasis (one with hypothyroidism,
one with Crohn’s disease, two with hyperthyroidism).
Their baseline DXA measurement was no different
from the remaining cohort (0.387 ± 0.07 versus 0.437 ± 0.01,P= 0.350). Twenty eight patients (61%) were defined as hav-
ing osteopenia on day one of the study; however, no patients
received renal replacement therapy using citrate anticoagula-
tion with calcium replacement, and no subjects received
regular selective serotonin reuptake inhibitors or serotonin
norepinephrine reuptake inhibitors (associated with lower
BMD) prior to critical illness. Further data regarding re-
cruitment and survival, as well as baseline laboratory
values, are available in Additional file 1.
Table 2 Bivariable and multivariable logistical analysis of bedside physiology versus 2% loss of bone mineral density
by day 10
Univariate Multivariate
Variable OR 95% CI P value OR 95% CI P value
Admission BMD 1.000 0.997-1.003 0.899
Change in RFCSA 1.019 0.971-1.070 0.439
Organ failure 1.078 1.005-1.157 0.037g
Age 0.980 0.946-1.015 0.268 0.977 0.939-1.059 0.935
CRPa 1.000 0.999-1.001 0.857
Chronic diseasee 1.385 0.417-4.602 0.595 1.266 0.167-9.596 0.819
Insulina,b 1.046 0.937-1.167 0.421
Proteina,b 1.034 0.941-1.136 0.491
Caloriesa,b 1.007 0.996-1.017 0.220
LMWHf 1.001 0.998-1.004 0.530
Unfractionated heparinf 1.000 1.000-1.000 0.518
All heparinf 1.000 1.000-1.000 0.725
Male sex 1.711 0.499-5.871 0.393 4.966 0.567-43.567 0.147
APACHE II 1.050 0.937-1.176 0.403
SAPS II 0.995 0.944-1.050 0.867
Admission SOFA 1.080 0.846-1.381 0.536
Temperature 0.788 0.489-1.270 0.328
Haemoglobin 1.047 0.794-1.381 0.744
White cell count 0.886 0.778-1.009 0.068
Platelets 0.994 0.988-1.000 0.053
INR 4.960 0.886-27.774 0.068
APTTR 2.830 0.403-19.873 0.296
Sodium 0.988 0.871-1.121 0.856
Potassium 0.475 0.160-1.411 0.180
Urea 0.999 0.891-1.121 0.992
Creatinine 1.001 0.990-1.011 0.914
Alkaline phosphatase 1.010 0.995-1.025 0.178
AST 1.003 0.999-1.006 0.097
Bilirubin 1.048 0.998-1.101 0.061 1.078 0.994-1.156 0.076
Albumin 1.027 0.944-1.117 0.539
Calciumg 1.974 1.116-3.492 0.020g 1.980 1.089-3.609 0.026
Phosphate 0.653 0.195-2.191 0.491
Magnesium 0.435 0.036-5.190 0.510
PaO2 0.836 0.659-1.061 0.141
SaO2 0.840 0.617-1.145 0.271
PaCO2 0.943 0.600-1.482 0.798
H+ 1.000 0.993-1.006 0.960
Base excess 0.967 0.812-1.151 0.706
Bicarbonate 1.024 0.839-1.249 0.815
Lactate 1.018 0.669-1.549 0.933
Chloride 1.047 .0935-1.172 0.424
Apparent SID 0.914 .0792-1.055 0.218
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Table 2 Bivariable and multivariable logistical analysis of bedside physiology versus 2% loss of bone mineral density
by day 10 (Continued)
Effective SID 0.641 0.933-1.118 0.641
Strong ion gap 0.968 0.905-1.035 0.338
Glucose day 1 0.923 0.622-1.370 0.692
MAP 1.010 0.947-1.077 0.768
Heart rate 0.994 0.960-1.029 0.735
PaO2/FiO2 ratio 0.943 0.890-1.000 0.050
g 0.916 0.833-0.998 0.044
SIRS 0.544 0.154-1.925 0.345
NMB use 1.154 0.742-1.795 0.524
Corticosteroid usec 1.000 1.000-1.001 0.856
RRT 1.094 0.291-4.109 0.894
HMGCoA used 2.000 0.483-8.275 0.339
Median glucosea 1.158 0.637-2.104 0.631
Days of intubation 0.988 0.923-1.057 0.724
LOS pre-admission 1.166 0.681-1.994 0.576
Organ failure was defined by SOFA scoring. All values are for day 1 of ICU admission, except awhich denotes area under curve for 10 days. bIndicates those
normalised to ideal body weight. cCorticosteroid doses calculated in hydrocortisone equivalents. dDenotes use on admission, and continued through study period.
eChronic disease defined by hospital and general practice coding for management of chronic disease. fIndicates cumulative dose. gcalcium variable, exponentially
transformed to allow logistic regression. Bold type indicates P <0.05.
APACHE II = Acute Physiology and Chronic Health Evaluation II score, APTTR = Activated partial thromboplastin time ratio, AST = Aspartate transaminase, CRP = C-reactive
protein, FiO2 = Fraction of inspired oxygen, HMGCoA RI = 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor treatment, INR = International normalised ratio, LMWH=
Low molecular weight heparin, LOS = Length of stay, NMB =Neuromuscular blockade, PaCO2 = Partial pressure of carbon dioxide in arterial blood, PaO2 = Partial pressure
of oxygen in arterial blood, RFCSA = Rectus Femoris cross-sectional area in 10 days, RRT = Renal replacement therapy, SaO2 = Oxygen saturation in arterial blood, SAPS 2 =
Simplified Acute Physiology Score 2, SID = Strong Ion Difference, SOFA = Sequential Organ Failure Assessment.
Figure 1 Change in T-score and percentage increase in fracture risk
in patients with (n = 34) and without (n = 12) acute respiratory distress
syndrome. FiO2 = Fraction of inspired oxygen, PaO2 = Partial pressure
of oxygen in blood. Mann-Whitney U test was performed between
groups, *P <0.05.
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BMD data were non-normally distributed prior to and fol-
lowing log transformation. There was no change in BMD
between day 1 and 10 in the cohort overall (0.434 (95%
CI: 0.405 to 0.463) versus 0.425 g/cm2 (95% CI: 0.399 to
0.450), P = 0.58). Multivariable logistical regression, ad-
justed for age, sex and chronic disease, was performed
using a threshold of 2% loss of BMD. The model (overall
model fit P <0.001, Hosmer-Lemeshow test P = 0.90,
Table 2) demonstrated that admission calcium corrected
for serum albumin (odds ratio (OR): 1.980 (95% CI: 1.089
to 3.609), P = 0.026) and the ratio of arterial partial pres-
sure of oxygen (PaO2) to fraction of inspired oxygen
(FiO2) on admission (OR: 0.916 (95% CI: 0.833 to 0.998),
P = 0.044) were associated with a greater than 2% loss of
BMD. Patient with acute respiratory distress syndrome
(ARDS) (PaO2-to-FiO2 ratio of less than 300 mmHg [17]
demonstrated greater BMD loss than those without
(−2.81% (95% CI: −5.73 to 0.118%), n = 34 versus 2.40%
(95% CI: 0.204 to 4.586%), n = 12, P = 0.029).
Change in T-score
Admission T-score in those with ARDS did not differ
from those without (−1.259 (95% CI: −1.737 to −0.781),
n = 34 versus −1.325 (95% CI: −1.969 to −0.681), n = 12,
P = 0.617), but ARDS patients had a change in T-score
from day 1 to day 10 (−1.259 (95% CI: −1.737 to −0.781),n = 34 versus −1.518 (95% CI: −1.922 to −1.114), P = 0.047)
compared to those without (−1.325 (95% CI: −1.969
to −0.681) versus −1.200 (95% CI: −1.798 to −0.602),
P = 0.101). In the 34 patients with ARDS, fracture risk
increased by 19.4% (95% CI: 13.9 to 25.0%) in the first
10 days of critical illness in comparison to those without
(9.35% (95% CI: −2.1 to 20.9%), P = 0.012, Figure 1).
Rawal et al. Critical Care  (2015) 19:165 Page 5 of 6Discussion
Clinical relevance
The relationship between loss of BMD and rise in serum
calcium concentration is to be expected. However, rapid
early bone demineralization, of similar magnitude to that
observed after much more prolonged weightlessness in
space [18], occurs rapidly and early in critically ill pa-
tients with ARDS. The association of ARDS with bone
demineralization is physiologically plausible: ARDS re-
sults in systemic release of inflammatory cytokines [19]
such as interleukin-6 [20], TNFα [20,21], interleukin-1
[21] and interleukin-8 [22], which stimulate osteoclasto-
genesis and bone resorption with calcium mobilized into
the circulation from these bone stores [23]. The scale of
this loss is associated with an increase in calculated pro-
spective fracture risk; an issue of some importance given
that ARDS survivors have a number of independent risk
factors for falls [24], including accelerated skeletal muscle
wasting [4] and marked loss of executive function [25].
Bone is certainly able to respond rapidly to remodelling
forces: changes are observed within 15 to 21 days in ro-
dent models of unloading [26,27], and markers of bone
turnover alter with single bouts of exercise in humans
[28]. However, we are unaware of studies of the human
skeletal response to illness over timeframes a short as that
which we have addressed. Whilst in vitro evidence exists
that hypoxia is detrimental to skeletal physiology and has
both an inhibitory effect on osteoblastogenesis [29] and an
activator-enhancing effect on osteoclastogenesis [30], no
relationship was seen with admission hypoxia, although
intermittent hypoxia as a stimulus cannot be excluded.
Limitations
Whilst acknowledging that the first day of ICU admis-
sion is not the first day of critical illness, the median
time to ICU admission was 24 hours, and 23 patients
were admitted after a sudden acute event (for example
trauma, myocardial infarction or intracranial bleed) with
no antecedent decline. Nonetheless, these data should
be considered hypothesis-generating. The limited sample
size also precludes detailed exploration of other risk fac-
tors, such as osteopaenia, and generalisation to specific
patient groups. Regrettably, we are unable to determine
whether the observed changes translated into clinical
skeletal events, given that this pilot study was not funded
for the post-discharge follow-up of patients. Larger obser-
vational cohort studies, with extended follow-up periods,
are required to determine the impact of critical illness on
BMD and actual fracture risk. The determination of calca-
neal BMD using DXA is valid and comparable to hip and
spine DXA in determining fracture risk [16,31], and is
more readily performed than the assessment of spine and
hip bone densitometry in a remote imaging facility during
the early stage of critical illness when the patient is mostunstable. The coefficient of variance of DXA measures
was 0.9%. A loss of more than 2% in calcaneal BMD (as
we sought) was thus likely to represent true loss as op-
posed to measurement error.
Conclusions
Rapid bone demineralization, associated with an increase
in fracture risk, was observed in critically ill patients
with ARDS. More extensive and extended hypothesis-
driven epidemiological cohort studies are required to
confirm this finding, and to determine whether bone de-
mineralisation represents a new therapeutic target in re-
ducing morbidity following critical illness.
Key messages
 Loss of bone mineral density occurs rapidly in
critically ill patients with acute respiratory distress
syndrome.
 This is likely to be associated with an increase in
fracture risk.
Additional file
Additional file 1: Supplementary data. 1.1 Baseline laboratory data. 1.2
Flowchart of patient recruitment and survival within study.
Abbreviations
ARDS: Acute Respiratory Distress Syndrome; BMD: Bone Mineral Density;
CI: Confidence interval; DXA: Dual X-ray Absorptiometry; FiO2: Fraction of
inspired oxygen; ICU: Intensive Care Unit; OR: Odds ratio; PaO2: Arterial partial
pressure of oxygen; SAPS II: Simplified acute physiology score; TNFα: tumor
necrosis factor alpha.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Concept and design: JR, JM, SH, NH, HM, and ZP. Data collection: JR, MM, GR,
PC, and ZP. Analysis and interpretation: JR, MM, GR, PC, HM, and ZP.
Manuscript drafting and revision: JR, MM, GR, JM, SH, NH, HE, and ZP. All
authors read and approved the final manuscript.
Acknowledgements
ZP is funded by the National Institute of Health Research (NIHR) UK. This research
was supported by the NIHR University College London Hospitals Biomedical
Research Centre (BRC). Additional funding was received from the European
Society of Intensive Care Medicine, Guy’s and St Thomas’ and King’s College
London NIHR Comprehensive Biomedical Research Centre and the Whittington
Hospital NHS Trust. MM is funded by the Wellcome Trust UK and acknowledges
the BRC at Imperial College and King’s College London for infrastructure support.
This paper was supported by Grant Number, DRF-2010-03-114.
The NIHR, the European Society of Intensive Care Medicine, Guy’s and St
Thomas’ and King’s College London NIHR Comprehensive BRC and the
Whittington Hospital NHS Trust had no role in the design and conduct of
the study; collection, management, analysis and interpretation of the data;
preparation, review or approval of the manuscript; or decision to submit the
manuscript for publication.
The authors are grateful to the patients and staff at both King’s College
Hospital and the Whittington Hospital NHS trust, without which this study
could not have been performed. ZP has full access to all data in the study
and takes responsibility for the integrity of the data and the accuracy of the
data analysis.
Rawal et al. Critical Care  (2015) 19:165 Page 6 of 6Author details
1Institute of Health and Human Performance, University College London,
Room 443, 74 Huntley Street, London WC1E 6AU, UK. 2Department of
Hepatology and Gastroenterology, St Mary’s Hospital, Imperial College
London, praed street, London W2 1NY, UK. 3Institute of Liver Studies, King’s
College Hospital NHS Foundation Trust, denmark hill, London SE59RS, UK.
4NIHR Comprehensive Biomedical Research Centre, Guy’s and St Thomas’
NHS Foundation Trust and King’s College London, Westminster Bridge Road,
London SE17EH, UK. 5King’s College London School of Medicine, denmark
hill, London SE59RS, UK. 6Centre of Human and Aerospace Physiological
Sciences, King’s College London, Great Maze Pond, London SE1 9RT, UK.
7Division of Respiratory and Critical Care, National University Hospital, 1E
Lower Kent Ridge Road, Singapore 119228, Singapore.
Received: 19 January 2015 Accepted: 20 March 2015
References
1. Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A,
et al. Functional disability 5 years after acute respiratory distress syndrome.
N Engl J Med. 2011;364:1293–304.
2. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N,
Al-Saidi F, et al. One-year outcomes in survivors of the acute respiratory
distress syndrome. N Engl J Med. 2003;348:683–93.
3. Iwashyna TJ. Survivorship will be the defining challenge of critical care in
the 21st century. Ann Intern Med. 2010;153:204–5.
4. Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, et al.
Acute skeletal muscle wasting in critical illness. JAMA. 2013;310:1591–600.
5. Chen JH, Liu C, You L, Simmons CA. Boning up on Wolff’s Law: mechanical
regulation of the cells that make and maintain bone. J Biomech.
2010;43:108–18.
6. Lang TF. The bone-muscle relationship in men and women. J Osteoporos.
2011;2011:702735.
7. Schoenau E. From mechanostat theory to development of the “Functional
Muscle-Bone-Unit”. J Musculoskelet Neuronal Interact. 2005;5:232–8.
8. Krolner B, Toft B. Vertebral bone loss: an unheeded side effect of
therapeutic bed rest. Clin Sci (Lond). 1983;64:537–40.
9. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of
bone resorption and inhibition of bone formation in vitro by human
tumour necrosis factors. Nature. 1986;319:516–8.
10. Bushinsky DA, Smith SB, Gavrilov KL, Gavrilov LF, Li J, Levi-Setti R. Acute
acidosis-induced alteration in bone bicarbonate and phosphate. Am J Physiol
Renal Physiol. 2002;283:F1091–7.
11. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L,
Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D.
J Clin Endocrinol Metab. 2003;88:4623–32.
12. Dubois EF, Roder E, Dekhuijzen PN, Zwinderman AE, Schweitzer DH. Dual
energy X-ray absorptiometry outcomes in male COPD patients after
treatment with different glucocorticoid regimens. Chest. 2002;121:1456–63.
13. Uzkeser H, Yildirim K, Aktan B, Karatay S, Kaynar H, Araz O, et al. Bone
mineral density in patients with obstructive sleep apnea syndrome. Sleep
Breath. 2013;17:339–42.
14. Smith LM, Cuthbertson B, Harvie J, Webster N, Robins S, Ralston SH.
Increased bone resorption in the critically ill: association with sepsis and
increased nitric oxide production. Crit Care Med. 2002;30:837–40.
15. Orford NR, Saunders K, Merriman E, Henry M, Pasco J, Stow P, et al. Skeletal
morbidity among survivors of critical illness. Crit Care Med. 2011;39:1295–300.
16. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry:
scientific review. JAMA. 2002;288:1889–97.
17. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E,
et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA.
2012;307:2526–33.
18. Lang T, LeBlanc A, Evans H, Lu Y, Genant H, Yu A. Cortical and trabecular
bone mineral loss from the spine and hip in long-duration spaceflight.
J Bone Miner Res. 2004;19:1006–12.
19. Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation
in acute lung injury. Cytokine Growth Factor Rev. 2003;14:523–35.
20. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of
inflammatory markers predict change in bone mineral density and
resorption in older adults: a longitudinal study. J Clin Endocrinol Metab.
2008;93:1952–8.21. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation.
Nature. 2003;423:337–42.
22. Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ. Interleukin-8
stimulation of osteoclastogenesis and bone resorption is a mechanism for
the increased osteolysis of metastatic bone disease. Bone. 2003;33:28–37.
23. Lieben L, Masuyama R, Torrekens S, Van Looveren R, Schrooten J, Baatsen P,
et al. Normocalcemia is maintained in mice under conditions of calcium
malabsorption by vitamin D-induced inhibition of bone mineralization.
J Clin Invest. 2012;122:1803–15.
24. Bagshaw SM, Stelfox HT, McDermid RC, Rolfson DB, Tsuyuki RT, Baig N, et al.
Association between frailty and short- and long-term outcomes among
critically ill patients: a multicentre prospective cohort study. CMAJ.
2014;186:E95–E102.
25. Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT,
et al. Long-term cognitive impairment after critical illness. N Engl J Med.
2013;369:1306–16.
26. Zhang B, Cory E, Bhattacharya R, Sah R, Hargens AR. Fifteen days of
microgravity causes growth in calvaria of mice. Bone. 2013;56:290–5.
27. Sun LW, Luan HQ, Huang YF, Wang Y, Fan YB. Effects of local vibration on
bone loss in -tail-suspended rats. Int J Sports Med. 2014;35:615–24.
28. Sherk VD, Chrisman C, Smith J, Young KC, Singh H, Bemben MG, et al. Acute
bone marker responses to whole-body vibration and resistance exercise in
young women. J Clin Densitom. 2013;16:104–9.
29. Nicolaije C, Koedam M, van Leeuwen JP. Decreased oxygen tension lowers
reactive oxygen species and apoptosis and inhibits osteoblast matrix
mineralization through changes in early osteoblast differentiation. J Cell
Physiol. 2012;227:1309–18.
30. Dandajena TC, Ihnat MA, Disch B, Thorpe J, Currier GF. Hypoxia triggers a
HIF-mediated differentiation of peripheral blood mononuclear cells into
osteoclasts. Orthod Craniofac Res. 2012;15:1–9.
31. Muschitz C, Dimai HP, Kocijan R, Kaider A, Zendeli A, Kuhne F, et al. The
discriminatory capacity of BMD measurements by DXA and dual X-ray and
laser (DXL) at the calcaneus including clinical risk factors for detecting
patients with vertebral fractures. Osteoporos Int. 2013;24:2181–90.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
